Canada's natural health product (NHP) regulatory framework is one of the most comprehensive in the world. Whether you're launching your first supplement brand or scaling an established line, understanding how Health Canada's system works is foundational to getting products to market — and keeping them there.
This guide walks through every layer of NHP compliance in Canada: what it means, how licencing works, how to navigate NPN applications, and how to use Health Canada's monograph system to your advantage.
What Is an NHP in Canada?
Under the Natural Health Products Regulations (NHPR), a natural health product is any substance sold for human health purposes that falls within a defined set of categories, including vitamins, minerals, herbal remedies, homeopathic medicines, traditional medicines, probiotics, and certain topical products.
Every NHP sold in Canada must carry either a Natural Product Number (NPN) or a Homeopathic Medicine Number (DIN-HM) on its label. These eight-digit identifiers confirm that Health Canada has reviewed and approved the product for safety, efficacy, and quality before it reaches consumers.
As of today, there are 127,779 active licensed NHP products in Canada — a figure that reflects the scale and complexity of the market that regulatory professionals and brand owners must navigate.
The NPN Application Process
Submitting a Product Licence Application
An NPN application — formally called a Product Licence Application (PLA) — is submitted through Health Canada's Natural and Non-prescription Health Products Directorate (NNHPD). The submission must include:
- Product information: name, dosage form, route of administration
- Medicinal ingredients: quantity, source, and potency
- Non-medicinal ingredients: full list with function
- Evidence of safety and efficacy: typically monograph references, published clinical data, or traditional use documentation
- Label draft: compliant with NHPR labelling requirements
Applications are reviewed under one of three evidence tracks: Monograph, Traditional Reference, or Full Product Licence (requiring independent clinical evidence).
Processing Times and Priorities
Health Canada uses a tiered system for review. Monograph-based submissions are the fastest route to market, as they rely on pre-assessed ingredient and claim combinations. Non-monograph submissions require a more intensive review and typically take longer.
For brand owners, the strategic implication is clear: if your formulation and intended claims align with an existing Health Canada monograph, building your application around it will significantly reduce both time-to-market and regulatory risk.
Understanding Health Canada Monographs
What Monographs Do
Health Canada monographs are pre-assessed documents that outline acceptable ingredients, doses, claims, and cautions for specific product categories. When your product licence application references a monograph, you're essentially citing Health Canada's own prior scientific assessment — which streamlines review considerably.
There are currently 249 Health Canada monographs covering a wide range of ingredient categories and product types.
Monograph Structure: Uses and Cautions
Each monograph specifies a list of approved health claims (referred to as "uses") and required label cautions. The breadth varies significantly by category:
| Monograph | Route | Approved Uses | Cautions |
|---|---|---|---|
| Fixed Oil Products | Oral | 57 | 5 |
| Workout Supplements | Oral | 39 | 37 |
| Dandelion (Taraxacum officinale) | Oral | 20 | 4 |
| Elder (Sambucus) | Oral | 18 | 4 |
| Mushrooms | Oral | 18 | 2 |
| Acne Therapy | Topical | 16 | 16 |
| Nicotinamide Mononucleotide | Oral | 15 | 2 |
| Primary Sunscreen | Topical | 15 | 6 |
The Workout Supplements monograph, for instance, carries 37 required cautions — one of the highest of any monograph — reflecting the complexity and risk profile of that product category.
Approved Claim Language
Monographs specify exact or near-exact claim wording that must appear on labels. Straying from this language — even slightly — can trigger a non-compliance finding. Examples of approved health claim formats include:
- "Helps to relieve pain associated with osteoarthritis of the knee"
- "Source of vitamin A"
- "Used in Herbal Medicine as an adaptogen to help increase energy and resistance to stress over time (e.g., in case of mental and physical fatigue related to stress)"
- "Traditionally used in Herbal Medicine to help relieve digestive disturbances (such as dyspepsia)"
- "Traditionally used in Ayurveda to aid digestion (Dipani)"
- "For temporary relief of pain of (minor) sore throat"
When combining traditional and modern claims on a single label — or when claims originate from multiple traditional medicine systems — the relevant ingredient and system must be named explicitly. As Health Canada's guidance states: "any indicated traditional use claim must refer to the specific medicinal ingredient(s) and recognised traditional system of medicine from which the claim originates."
Dose-level constraints can also appear within monograph claim language. For example, omega-3 products must note that "the combined maximum daily dose of EPA+DHA in a single product must not exceed 5,000 mg for 18 years and older per day."
The Ingredients Landscape
Most Common Medicinal Ingredients
The Licensed Natural Health Products Database (LNHPD) contains 6,210 unique medicinal ingredients across all active licences. However, the market is heavily concentrated around a core set of vitamins and minerals:
| Ingredient | Licensed Products |
|---|---|
| Vitamin C | 10,828 |
| Vitamin D | 9,445 |
| Vitamin B6 | 8,512 |
| Zinc | 8,228 |
| Vitamin B12 | 8,204 |
| Magnesium | 7,920 |
| Vitamin E | 6,751 |
| Folate | 6,558 |
| Calcium | 6,395 |
| Thiamine | 5,862 |
These top-tier ingredients appear across tens of thousands of products precisely because they are well-supported by monograph evidence and have predictable approval pathways.
Dosage Forms and What They Mean for Compliance
The physical form of your product affects labelling requirements, stability data expectations, and sometimes the evidence standard required. The most common dosage forms across licensed NHPs in Canada are:
- Capsule: 38,994 products
- Granules: 14,695 products
- Tablet: 14,667 products
- Powder: 14,162 products
- Liquid: 10,559 products
- Soft capsule: 5,895 products
- Oral drops: 3,846 products
- Hard capsule: 3,545 products
Capsules dominate the market by a significant margin. For formulations targeting niche delivery mechanisms — oral drops, for example — the smaller approval volumes reflect both lower consumer demand and, in some cases, additional regulatory complexity around dose metering and stability.
Labelling Requirements Under the NHPR
Compliant NHP labels must include:
- The NPN or DIN-HM number prominently displayed
- A bilingual label (English and French) for products sold nationally
- Recommended dose, including age-specific dosing where relevant
- Duration of use, if applicable
- Risk information (cautions, warnings, contraindications, known adverse reactions)
- Storage conditions
- Lot number and expiry date
- Name and address of the licence holder
Health Canada's label requirements are not aspirational — they are enforceable conditions of your product licence. A product sold with non-compliant labelling can be recalled or have its licence suspended.
Site Licencing and Good Manufacturing Practices
Beyond product licencing, every facility that manufactures, packages, labels, or imports NHPs for sale in Canada must hold a Site Licence issued by Health Canada. Site licences are tied to GMP (Good Manufacturing Practices) compliance under Part 3 of the NHPR.
GMP requirements cover:
- Premises and equipment standards
- Personnel qualifications and training
- Quality assurance systems
- Testing of raw materials and finished products
- Record-keeping and batch documentation
Contract manufacturers, toll manufacturers, and importers are all subject to site licencing. Brand owners who don't operate their own facilities still bear responsibility for ensuring their supply chain is appropriately licenced.
Post-Market Obligations
Receiving an NPN is not the end of your compliance obligations — it's the beginning of an ongoing programme. Licence holders must:
- Report serious adverse reactions within 15 calendar days of becoming aware
- Maintain records of all complaints, quality failures, and adverse event investigations
- Notify Health Canada of any changes to the product (formulation, label, manufacturer, dosage form) that may require an amended licence
- Respond to compliance inspections and market surveillance activities
Health Canada's post-market surveillance programme is active and growing. Products that generate adverse event reports or consumer complaints may be subject to label reviews, mandatory recalls, or licence suspension.
Common Compliance Failures to Avoid
The most frequent reasons NHP applications are rejected or products fall into non-compliance include:
- Claim language that deviates from monograph wording — even minor paraphrasing can constitute an unapproved claim
- Incorrect or missing cautions — high-caution monographs like Acne Therapy (16 cautions) and Workout Supplements (37 cautions) require precise label reproduction
- Unlicenced medicinal ingredients — every active ingredient must appear in the approved licence
- Missing bilingual labelling — required for all nationally distributed products
- Non-compliant health claims on marketing materials — the NHPR applies to all promotional content, not just the physical label
Check Your Product
NHP compliance in Canada is a moving target — monographs are updated, new ingredients are added to the LNHPD, and Health Canada's enforcement priorities evolve. Staying current manually is time-consuming and error-prone.
BareGold is Canada's AI-powered NHP compliance engine. Cross-reference your formulation against all 127,779 licensed products and 249 Health Canada monographs, validate your claims against approved language, and identify gaps before you submit — or before an inspector does.